Current therapy of pemphigus vulgaris

Michael J. Fellner, Allen N. Sapadin

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Pemphigus vulgaris (PV) is a potentially fatal autoimmune blistering disease of the skin and mucous membranes, characterized by flaccid bullae that rupture and leave erosions. Its treatment is challenging. Although the use of systemic corticosteroids remains the cornerstone of effective therapeutic regimens for PV, their prolonged administration may lead to serious side effects. It is therefore necessary, for many patients, to add immunosuppressive agents or use immunomodulatory procedures to achieve remission. This paper will summarize the treatments available for PV, while focusing on the most recently available therapeutic options.

Original languageEnglish
Pages (from-to)268-278
Number of pages11
JournalMount Sinai Journal of Medicine
Issue number4-5
StatePublished - Sep 2001


  • Pemphigus vulgaris
  • Therapy


Dive into the research topics of 'Current therapy of pemphigus vulgaris'. Together they form a unique fingerprint.

Cite this